Steven E. Nissen - Publications, H-index & Citations

Steven E. Nissen

cleveland clinic

91H指数

673论文数

6.3W被引数

收录论文 239

发表时间

Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)利波迪西兰（一种靶向脂蛋白(a)的长效siRNA）对脂蛋白(a)氧化磷脂的影响

Journal of the American College of Cardiology

IF22.3

2026-08-31

OAAI

Steven E. Nissen; Ann Marie Navar; John H. Krege; Wei Ni; Julie St. John; Stephen J. Nicholls; Xi Shen; Kathy Wolski; Laura F. Michael

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial Kylo-11的安全性及降低脂蛋白(a)效果：一种非典型、长效小干扰RNA靶向脂蛋白(a)的首次人体、随机、双盲、安慰剂对照、1期临床试验

The Lancet

IF88.5

2026-08-28

PREAI

Ashish Sarraju; Xiaolin Du; Luping Zhou; Luke J Laffin; Kathy Wolski; Yumei Gu; Ziyang Liu; Qinsheng Zhang; Kunyuan Cui; Xiaolan Yong; Steven E Nissen

Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension 托拉马森在未控制高血压患者中的疗效

JACC

IF0

2026-05-12

OAAI

Luke J. Laffin; Qiuqing Wang; Ashish Sarraju; Rhian M. Touyz; Markus P. Schlaich; Debbie L. Cohen; Felix Mahfoud; Lisa M. Mitchell; Jennifer Mitchell; Kathy Wolski; Patrick Dennis; Ayoade Akere; Wanying Li; Gene Chen; Yehuda Z. Cohen; Jessica Kim; Caroline G. Cooper; Prameela Ramesan; Jay M. Edelberg; Steven E. Nissen

Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial 作者更正：奥昔特瑞匹在杂合子家族性高胆固醇血症患者中的应用：布鲁克林随机临床试验

Nature Medicine

IF50

2026-04-17

PREAI

Stephen J. Nicholls; Adam J. Nelson; Marc Ditmarsch; John J. P. Kastelein; Christie M. Ballantyne; Kausik K. Ray; Ann Marie Navar; Steven E. Nissen; Anne C. Goldberg; Liam R. Brunham; Erin Wuerdeman; Annie L. Neild; Douglas Kling; Andrew Hsieh; Julie Butters; Brian A. Ference; Ulrich Laufs; Maciej Banach; Roxana Mehran; Alberico L. Catapano; Michael Szarek; Violeta Balinskaite; Michael H. Davidson

Novel risk model for predicting incident atrial fibrillation in patients taking ω−3 fatty acid: sub-analysis of the STRENGTH randomized trial 新型风险模型用于预测服用ω-3脂肪酸患者中新发心房颤动：STRENGTH随机试验的亚组分析

American Journal of Preventive Cardiology

IF5.9

2026-03-27

OAAI

Tom Kai Ming Wang; Stephen J. Nicholls; Clement Tan; Becky Yi-Wen Liao; Kathy Wolski; Julie St John; Steven E Nissen

Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screening 识别ASCVD试验参与者的严重高胆固醇血症：对试验实施和机会性筛查的启示

Journal of Clinical Lipidology

IF4.6

2026-03-27

OAAI

Abhayjit Singh; Julie St. John; Luke Laffin; Joshua W. Knowles; Fatima Rodriguez; Warren Skoza; Dennis Bruemmer; Leslie Cho; Steven E. Nissen; Ashish Sarraju

Automating Chart Review Utilizing an Artificial Intelligence-Enabled System for Assessing Transthyretin Amyloid Cardiomyopathy Trial Eligibility 利用人工智能赋能系统自动化图表审查以评估转甲状腺素蛋白淀粉样变性心肌病试验的资格

Journal of Cardiac Failure

IF8.2

2026-03-03

OAAI

Trejeeve Martyn; Mazen Hanna; Steven E. Nissen; Harsh Patolia; Judah Rajendran; Weiqi Sun; Eirini Schlosser; Jason Cannavale; Konstantinos Bakogiannis; W.H. Wilson Tang; Amanda Vest; Olga Tasopoulou; Aikaterini Karathanasopoulou; Leslie Cho; Lars G. Svensson; Vaibhav Mavi; Aaron Gerds; Samir Kapadia; Lara Jehi; Ashish Sarraju

Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial Obicetrapib治疗杂合子家族性高胆固醇血症: 布鲁克林随机临床试验

Nature Medicine

IF50

2026-02-27

PREAI

Inaccurate information regarding cardiovascular disease prevention enabled by generative artificial intelligence 生成性人工智能支持的关于心血管疾病预防的不准确信息

American Journal of Preventive Cardiology

IF5.9

2026-01-01

OAAI

Astefanos Al-Dalakta; Bianca Honnekeri; Fatima Rodriguez; Luke Laffin; Vikas Sunder; Dennis Bruemmer; Leslie Cho; Steven E. Nissen; Ashish Sarraju

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes 在2型糖尿病中，替西帕肽与度拉糖肽的心血管结局比较

New England Journal of Medicine

IF78.5

2025-12-18

PREAI

Nicholls, Stephen J.; Pavo, Imre; Bhatt, Deepak L.; Buse, John B.; Del Prato, Stefano; Kahn, Steven E.; Lincoff, A. Michael; McGuire, Darren K.; Miller, Debra; Nauck, Michael A.; Nishiyama, Hiroshi; Nissen, Steven E.; Sattar, Naveed; Weerakkody, Govinda; Wiese, Russell J.; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Davies, Melanie J.; Giorgino, Francesco; Kellerer, Monika; Ji, Linong; Varkonyi, Tamas; Menon, Venu; Broder, Jonathan C.; Herschtal, Alan; D'Alessio, David

Lack of Impact of Adjunctive Lipid-Modifying Therapy in the CLEAR Outcomes Trial CLEAR Outcomes试验中辅助降脂治疗缺乏疗效

Journal of Clinical Lipidology

IF4.6

2025-11-04

PREAI

Venu Menon; LeAnne Bloedon; Na Li; A. Michael Lincoff; Stephen J. Nicholls; Heather A. Powell; Steven E. Nissen

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 I期临床试验：靶向ANGPTL3的CRISPR-Cas9基因编辑

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-11-01

PREAI

Laffin, Luke J.; Nicholls, Stephen J.; Scott, Russell S.; Clifton, Peter M.; Baker, John; Sarraju, Ashish; Singh, Shweta; Wang, Qiuqing; Wolski, Kathy; Xu, Huansheng; Nielsen, Jen; Patel, Naimish; Duran, Jason M.; Nissen, Steven E.

JCL Roundtable: Novel Lipid Management JCL圆桌会议：新型脂质管理

Journal of Clinical Lipidology

IF4.6

2025-09-23

PREAI

Steven E. Nissen; Ann Marie Navar; Daniel Gaudet; Kevin C. Maki

Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity 糖尿病和肥胖患者代谢手术与GLP-1受体激动剂在宏血管和微血管结局方面的比较

Nature Medicine

IF50

2025-09-16

PREAI

Hamlet Gasoyan; Mohammad Hesam Alavi; Alexander Zajichek; Nicholas J. Casacchia; Abdullah Al Jabri; James Bena; Xiaoxi Feng; Rickesha Wilson; Ricard Corcelles; W. Scott Butsch; Rishi P. Singh; Nikhil Das; Hejin Jeong; Amgad Mentias; W. H. Wilson Tang; Bartolome Burguera; Raul J. Rosenthal; Steven E. Nissen; Michael B. Rothberg; Ali Aminian

From LDL-C to Lipoprotein(a) - Those Who Fail to Learn from History Are Doomed to Repeat It 从LDL-C到Lipoprotein(a)——那些未能从历史中吸取教训的人注定会重蹈覆辙

American Journal of Preventive Cardiology

IF5.9

2025-09-04

OAAI

Ashish Sarraju; Steve E Nissen

Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid Clinical Insights From CLEAR Outcomes 降低尿酸疗法与痛风的关联：贝美泊酸的临床见解——来自CLEAR Outcomes研究

JACC-ADVANCES

IF0

2025-09-01

OAAI

Ray, Kausik K.; Nicholls, Stephen J.; Lincoff, A. Michael; Li, Na; Powell, Heather A.; Herout, Peter M.; Bloedon, LeAnne; Nissen, Steven E.

Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy 在非梗阻性肥厚型心肌病中 mavacamten 的超声心动图变化

JACC

IF0

2025-08-27

PREAI

Milind Y. Desai; Yuichiro Okushi; Shada Jadam; Iacopo Olivotto; Anjali Owens; Steven E. Nissen; Zoran B. Popovic; Pablo Garcia-Pavia; Renato D. Lopes; Perry M. Elliott; Fabio Fernandes; Jeffrey B. Geske; Lars Maier; Kathy Wolski; Qiuqing Wang; Wael Jaber; Zhiqun Gong; Victoria Florea; Matthew Fronheiser; Arlene Leva; Ron Aronson; Theodore Abraham

Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy Mavacamten对非梗阻性肥厚型心肌病心脏生物标志物的影响

JACC

IF0

2025-08-27

PREAI

Milind Y. Desai; Iacopo Olivotto; Theodore Abraham; Steven E. Nissen; Pablo Garcia-Pavia; Renato D. Lopes; Perry M. Elliott; Fabio Fernandes; Edileide de Barros Correia; Roberto Barriales-Villa; Esther Zorio; Michael Arad; Sung-Hee Shin; Nicolas Verheyen; Benjamin Meder; Olga Azevedo; Hiroaki Kitaoka; Kathy Wolski; Qiuqing Wang; Bharat Suryawanshi; Zhaoqing Wang; Victoria Florea; Ron Aronson; Anjali T. Owens

Reply 回复

jacc heart failure

IF0

2025-06-09

PREAI

Milind Y. Desai; Steven E. Nissen; Theodore Abraham; Anjali Owens; Iacopo Olivotto;

Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial ω-3脂肪酸在高心血管风险亚洲人与非亚洲人患者中心血管影响的差异：strength随机临床试验的亚组分析

Atherosclerosis

IF5.7

2025-05-28

OAAI

Tom Kai Ming Wang; Stephen J. Nicholls; Julie St John; Kathy Wolski; Steven E. Nissen

研究方向